Details for Patent: 4,772,473
✉ Email this page to a colleague
Summary for Patent: 4,772,473
Title: | Nitrofurantoin dosage form |
Abstract: | The invention involves a combination sustained release/rapid release pharmaceutical capsule for oral administration of nitrofurantoin comprising, in a capsule shell, a first layer of a first particulate mixture comprising nitrofurantoin, polyvinylpyrrolidone and carboxyvinylpolymer; and a second layer of a second particulate mixture comprising macrocrystalline nitrofurantoin. |
Inventor(s): | Patel; Vikram S. (Norwich, NY), Welles; Harry L. (Norwich, NY) |
Assignee: | Norwich Eaton Pharmaceuticals, Inc. (Norwich, NY) |
Application Number: | 06/874,943 |
Patent Claim Types: see list of patent claims | Composition; Dosage form; |
Drugs Protected by US Patent 4,772,473
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 4,772,473
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Austria | 398166 | ⤷ Sign Up | |||
Austria | A151687 | ⤷ Sign Up | |||
Australia | 592731 | ⤷ Sign Up | |||
Australia | 7421187 | ⤷ Sign Up | |||
Canada | 1288050 | ⤷ Sign Up | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |